Teng‐Yu Lee

3.3k total citations
85 papers, 1.6k citations indexed

About

Teng‐Yu Lee is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Teng‐Yu Lee has authored 85 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Hepatology, 51 papers in Epidemiology and 24 papers in Surgery. Recurrent topics in Teng‐Yu Lee's work include Liver Disease Diagnosis and Treatment (40 papers), Hepatitis B Virus Studies (33 papers) and Hepatitis C virus research (31 papers). Teng‐Yu Lee is often cited by papers focused on Liver Disease Diagnosis and Treatment (40 papers), Hepatitis B Virus Studies (33 papers) and Hepatitis C virus research (31 papers). Teng‐Yu Lee collaborates with scholars based in Taiwan, United States and South Korea. Teng‐Yu Lee's co-authors include Chun‐Ying Wu, Jaw‐Town Lin, Ming‐Shiang Wu, Hsiu J. Ho, Yao‐Chun Hsu, Shou‐Wu Lee, Chi‐Sen Chang, Chien‐Wei Su, Shen-Yung Wang and Jaw‐Ching Wu and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Teng‐Yu Lee

77 papers receiving 1.6k citations

Peers

Teng‐Yu Lee
Yoshihiko Ooka Japan
Catherine Frenette United States
Alexander Dechêne Germany
Hélène Agostini France
Joseph K. Lim United States
Maximilian Schöniger–Hekele Austria
Teiji Kuzuya Japan
Kyu Won Chung South Korea
Yoji Ishizu Japan
L Ruíz del Arbol Spain
Yoshihiko Ooka Japan
Teng‐Yu Lee
Citations per year, relative to Teng‐Yu Lee Teng‐Yu Lee (= 1×) peers Yoshihiko Ooka

Countries citing papers authored by Teng‐Yu Lee

Since Specialization
Citations

This map shows the geographic impact of Teng‐Yu Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teng‐Yu Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teng‐Yu Lee more than expected).

Fields of papers citing papers by Teng‐Yu Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teng‐Yu Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teng‐Yu Lee. The network helps show where Teng‐Yu Lee may publish in the future.

Co-authorship network of co-authors of Teng‐Yu Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Teng‐Yu Lee. A scholar is included among the top collaborators of Teng‐Yu Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teng‐Yu Lee. Teng‐Yu Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lin, Yu‐Sheng, et al.. (2026). Liver Steatosis‐Related Polygenic Risk Score Predicts Hepatocellular Carcinoma Risk After Hepatitis C Virus Eradication. Alimentary Pharmacology & Therapeutics. 3 indexed citations
3.
Huang, Yi‐Jie, Jun‐Sing Wang, Cheng‐Hsu Chen, et al.. (2025). Determinants of outcomes in patients with hepatitis B virus-decompensated cirrhosis. Scientific Reports. 15(1). 562–562. 1 indexed citations
4.
Tseng, Cheng‐Hao, Teng‐Yu Lee, Chi‐Yi Chen, et al.. (2025). Incidences of Virological and Clinical Relapses After Cessation of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Entecavir in Patients With HBeAg‐Negative Chronic Hepatitis B. Journal of Gastroenterology and Hepatology. 40(5). 1245–1254.
5.
6.
Hsu, Yao‐Chun, Chi-Yi Chen, Cheng‐Hao Tseng, et al.. (2024). Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial. Clinical and Molecular Hepatology. 31(1). 213–226.
7.
Hsu, Yao‐Chun, Teng‐Yu Lee, Mindie H. Nguyen, et al.. (2023). Severe hepatitis B flares with hepatic decompensation after withdrawal of nucleos(t)ide analogues: A population‐based cohort study. Alimentary Pharmacology & Therapeutics. 58(4). 463–473. 10 indexed citations
8.
Wu, Ming‐Ju, Cheng‐Hsu Chen, Sheng‐Shun Yang, et al.. (2023). Risk Stratification for Hepatitis B Virus Reactivation in Kidney Transplant Recipients With Resolved HBV Infection. Transplant International. 36. 11122–11122. 3 indexed citations
9.
Huang, Yen-Hsiang, Kun‐Chieh Chen, Kuo-Hsuan Hsu, et al.. (2022). Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment. Journal of Clinical Medicine. 12(1). 231–231. 6 indexed citations
10.
Chuang, Ya‐Wen, et al.. (2018). Using the chronic kidney disease guidelines to evaluate the renal safety of tenofovir disoproxil fumarate in hepatitis B patients. Alimentary Pharmacology & Therapeutics. 47(12). 1673–1681. 20 indexed citations
11.
Lee, Shou‐Wu, Teng‐Yu Lee, Sheng‐Shun Yang, et al.. (2018). Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population. Hepatobiliary & pancreatic diseases international. 17(1). 45–48. 25 indexed citations
12.
Lee, Shou‐Wu, Teng‐Yu Lee, Sheng‐Shun Yang, et al.. (2018). Prevalence of Hepatitis B Reactivation Among Chinese Individuals With Chronic Hepatitis C Treated With Pan-Oral Direct-Acting Antivirals. Gastroenterology Research. 11(2). 124–129. 8 indexed citations
13.
Lee, Shou‐Wu, et al.. (2017). The Diagnostic Value of Alarm Features for Identifying Types and Stages of Upper Gastrointestinal Malignancies. Gastroenterology Research. 10(2). 120–125. 10 indexed citations
14.
Lee, Shou‐Wu, Teng‐Yu Lee, Sheng‐Shun Yang, Hong‐Zen Yeh, & Chi‐Sen Chang. (2016). Two-year Single-Center Real-Life Data of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B Patients in Taiwan. Journal of Gastroenterology and Hepatology Research. 5(2). 2010–2014.
15.
Lee, Shou‐Wu, Han‐Chung Lien, Chi‐Sen Chang, et al.. (2016). Association of metabolic syndrome with erosive esophagitis and Barrett’s esophagus in a Chinese population. Journal of the Chinese Medical Association. 80(1). 15–18. 9 indexed citations
16.
Wu, Chun‐Ying, Yao‐Chun Hsu, Hsiu J. Ho, et al.. (2015). Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: a nationwide cohort study. Gut. 65(4). 693–701. 57 indexed citations
17.
Lee, Shou‐Wu, Teng‐Yu Lee, Han‐Chung Lien, et al.. (2014). Characteristics of Symptom Presentation and Risk Factors in Patients with Erosive Esophagitis and Nonerosive Reflux Disease. Medical Principles and Practice. 23(5). 460–464. 8 indexed citations
18.
Wu, Chun‐Ying, Jaw‐Town Lin, Hsiu J. Ho, et al.. (2014). Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B—A Nationwide Cohort Study. Gastroenterology. 147(1). 143–151.e5. 248 indexed citations
19.
Wu, Chen‐Shiou, Teng‐Yu Lee, Ruey‐Hwang Chou, et al.. (2014). Development of a Highly Sensitive Glycan Microarray for Quantifying AFP-L3 for Early Prediction of Hepatitis B Virus–Related Hepatocellular Carcinoma. PLoS ONE. 9(6). e99959–e99959. 22 indexed citations
20.
Lee, Teng‐Yu, et al.. (2013). Osteopontin Promoter Polymorphisms are Associated With Susceptibility to Gastric Cancer. Journal of Clinical Gastroenterology. 47(6). e55–e59. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshihiko Ooka Breakdown of academic impact, for papers by Catherine Frenette Breakdown of academic impact, for papers by Alexander Dechêne Breakdown of academic impact, for papers by Hélène Agostini Breakdown of academic impact, for papers by Joseph K. Lim Breakdown of academic impact, for papers by Maximilian Schöniger–Hekele Breakdown of academic impact, for papers by Teiji Kuzuya Breakdown of academic impact, for papers by Kyu Won Chung Breakdown of academic impact, for papers by Yoji Ishizu Breakdown of academic impact, for papers by L Ruíz del Arbol
Rankless by CCL
2026